World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
21504
World Ranking
18074
National Ranking
602

Pierre Wolkenstein publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pierre Wolkenstein sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 540 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pierre Wolkenstein D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pierre Wolkenstein sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Pierre Wolkenstein is affiliated with Assistance Publique - Hôpitaux de Paris in France. Their research primarily focuses on the field of Medicine, with a significant number of publications contributing to subfields such as Neurology, Rheumatology, Dermatology, Pathology and Forensic Medicine, and Pharmacology.

The main topics covered in their work include:

  • Neurofibromatosis and Schwannoma Cases
  • Drug-Induced Adverse Reactions
  • Autoimmune Bullous Skin Diseases
  • Soft tissue tumor case studies
  • Urticaria and Related Conditions
  • Contact Dermatitis and Allergies
  • Sarcoma Diagnosis and Treatment

Wolkenstein has published extensively in several scientific journals. Frequent venues for their work include:

  • Annales de Dermatologie et de Vénéréologie - FMC
  • Annales de Dermatologie et de Vénéréologie
  • Journal of the European Academy of Dermatology and Venereology
  • Journal of Investigative Dermatology
  • British Journal of Dermatology

Among their recent papers are

  • "Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation" (2021), published in Genetics in Medicine
  • "Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation" (2022), published in Genetics in Medicine
  • "Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966" (2020), published in Orphanet Journal of Rare Diseases
  • "Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database" (2022), published in Scientific Reports
  • "Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome" (2020), published in European Journal of Human Genetics

Collaborations have been an important aspect of Wolkenstein's research activity. Frequent coauthors include:

  • S. Oro
  • S. Ferkal
  • L. Fertitta
  • Christina Bergqvist
  • É. Sbidian

Best Publications

  • SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis

    Sylvie Bastuji-Garin;Nathalie Fouchard;M Bertocchi;Jean-Claude Roujeau

  • Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies

    Jean E. Revuz;Florence Canoui-Poitrine;Pierre Wolkenstein;Cedric Viallette

  • Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis

    Pierre Wolkenstein;Jacques Latarjet;Jean-Claude Roujeau;Corinne Duguet

  • Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells

    Amal Nassif;Armand Bensussan;Laurence Boumsell;Aurelien Deniaud

  • Quality of life impairment in hidradenitis suppurativa : A study of 61 cases

    Pierre Wolkenstein;Anderson Loundou;Karine Barrau;Pascal Auquier

  • Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis

    C. Paul;P. Wolkenstein;H. Adle;J. Wechsler

  • Severe cutaneous adverse reactions to drugs.

    Tu Anh Duong;Laurence Valeyrie-Allanore;Pierre Wolkenstein;Olivier Chosidow

  • Patch testing in severe cutaneous adverse drug reactions, including Stevens‐Johnson syndrome and toxic epidermal necrolysis

    P Wolkenstein;O Chosidow;M L Fléchet;O Robbiola

  • Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study.

    Laurent Lantieri;Jean-Paul Meningaud;Philippe Grimbert;Frank Bellivier

  • Elevated risk for MPNST in NF1 microdeletion patients.

    T. De Raedt;H. Brems;P. Wolkenstein;D. Vidaud

  • Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity.

    Florence Canoui-Poitrine;Florence Canoui-Poitrine;Jean E. Revuz;Pierre Wolkenstein;Cédric Viallette

  • Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.

    Jean-Sébastien Guillamo;Alain Créange;Chantal Kalifa;Jacques Grill

  • Association between benign and malignant peripheral nerve sheath tumors in NF1.

    T. Tucker;P. Wolkenstein;J. Revuz;J. Zeller

  • Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.

    G. Gener;F. Canoui-Poitrine;J.E. Revuz;O. Faye

  • Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

    L. Valeyrie-Allanore;P. Wolkenstein;L. Brochard;N. Ortonne

  • Neurological complications of neurofibromatosis type 1 in adulthood.

    A. Créange;J. Zeller;S. Rostaing-Rigattieri;P. Brugières

  • Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1.

    Angela E. Lin;Patricia H. Birch;Bruce R. Korf;Romano Tenconi

  • Identification of Three Hidradenitis Suppurativa Phenotypes: Latent Class Analysis of a Cross-Sectional Study

    Florence Canoui-Poitrine;Aurélie Le Thuaut;Jean E Revuz;Cédric Viallette

  • Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study

    F. Lebargy;P. Wolkenstein;M. Gisselbrecht;F. Lange

  • NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype†

    Eric Pasmant;Audrey Sabbagh;Gillian Spurlock;Ingrid Laurendeau

Frequent Co-Authors

Olivier Chosidow
Olivier Chosidow Université Paris Cité
Jean Revuz
Jean Revuz Université Paris Cité
Martine Bagot
Martine Bagot Université Paris Cité
Jean-Claude Roujeau
Jean-Claude Roujeau Université Paris Cité
Nicolas Dupin
Nicolas Dupin Université Paris Cité
Ivan Bièche
Ivan Bièche Institute Curie
Bernard Grandchamp
Bernard Grandchamp Université Paris Cité
Céleste Lebbé
Céleste Lebbé Hôpitaux Universitaires Paris-Ouest
Christian Brun-Buisson
Christian Brun-Buisson Institut Pasteur
Jean-Jacques Grob
Jean-Jacques Grob Aix-Marseille University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA remains highly competitive, there are many related online degrees and career pathways that offer versatility and accessible entry points into healthcare. These programs appeal to those seeking flexible, affordable alternatives or looking to specialize in the medical field without traditional medical school.

For those interested in pharmacy, online pharmd programs make it possible to earn an advanced pharmacy degree remotely—ideal for working professionals. Meanwhile, the rise of technology-driven healthcare is fueling demand for digital experts. Health informatics degrees focus on managing medical data and technology, paving the way for careers at the intersection of healthcare and IT.

Entry-level programs like billing and coding classes online prepare students for specialized roles supporting healthcare administration. These courses are often short and lead to quickly employable certifications.

Those seeking advanced clinical roles can explore affordable np programs, which train registered nurses to become nurse practitioners with expanded responsibilities and autonomy.

Best Scientists Citing Pierre Wolkenstein

Trending Scientists

Recently Published Articles